Back
Kura Oncology Vs. Armata Pharmaceuticals Industry Stock Comparison
Sell
41
KURA
Kura Oncology
Last Price:
16.50
Seasonality Move:
16.24%
Buy
86
ARMP
Armata Pharmaceuticals
Last Price:
2.69
Seasonality Move:
12.82%
Sell
41
Kura Oncology (KURA)
is a Sell
Is Kura Oncology a Buy, Sell or Hold?
- The current Kura Oncology [KURA] share price is $16.49. The Score for KURA is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
- KURA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
86
Armata Pharmaceuticals (ARMP)
is a Buy
Is Armata Pharmaceuticals a Buy, Sell or Hold?
- The current Armata Pharmaceuticals [ARMP] share price is $2.68. The Score for ARMP is 86, which is 72% above its historic median score of 50, and infers lower risk than normal.
- ARMP is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
KURA Stock Price Chart
What is Kura Oncology's stock price today?
-
The Kura Oncology share price today is $16.49
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KURA is experiencing selling pressure, which indicates risk of future bearish movement.
ARMP Stock Price Chart
What is Armata Pharmaceuticals's stock price today?
-
The Armata Pharmaceuticals share price today is $2.68
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ARMP is experiencing selling pressure, which indicates risk of future bearish movement.
KURA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.28 | Sell |
| Relative Strength Index (14 RSI): | 38.17 | Sell |
| Chaikin Money Flow: | -658040 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (17.12 - 18.18) | Sell |
| Bollinger Bands (100): | (18.08 - 20.9) | Sell |
ARMP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.06 | Buy |
| Relative Strength Index (14 RSI): | 64.56 | Buy |
| Chaikin Money Flow: | -1753 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.25 - 2.51) | Buy |
| Bollinger Bands (100): | (2.24 - 2.76) | Buy |
KURA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 17.65 | Sell |
| 20-day SMA: | 17.5 | Sell |
| 50-day SMA: | 18.6 | Sell |
| 200-day SMA: | 20.14 | Sell |
| 8-day EMA: | 17.49 | Sell |
| 20-day EMA: | 17.68 | Sell |
| 50-day EMA: | 18.37 | Sell |
| 200-day EMA: | 18.55 | Sell |
ARMP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.43 | Buy |
| 20-day SMA: | 2.38 | Buy |
| 50-day SMA: | 2.34 | Buy |
| 200-day SMA: | 2.84 | Sell |
| 8-day EMA: | 2.51 | Buy |
| 20-day EMA: | 2.42 | Buy |
| 50-day EMA: | 2.4 | Buy |
| 200-day EMA: | 2.63 | Buy |
Kura Oncology Earnings Growth & KURA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.36 per share, and a decrease next year of $0.25 per share.
Armata Pharmaceuticals Earnings Growth & ARMP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.01 per share, and an increase next year of $0.52 per share.
Kura Oncology Technical Analysis
| Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Armata Pharmaceuticals Technical Analysis
| Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||